ANXA1 and COVID-19: In addition, it has been reported that ANXA1-FPR1 is generally upregulated in peripheral blood immune cells of critically ill patients during the onset of COVID-19, suggesting that critically ill patients may have a systemic immune response storm mediated by ANXA1-FPR1.